REFERENCES
- Anderssohn M, Schwedhelm E, Luneburg N, . Asymmetric dimethyl arginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus. Diab Vasc Dis Res. 2010;7:105–118.
- Futrakul N, Futrakul P. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes. Int J Vasc Med. 2011;2011:971524.
- Futrakul N, Futrakul P. Renal microvascular disease predicts renal disease in diabetic patients. Ren Fail. 2012;34:126–129.
- Ritt M, Ott C, Raff U, . Renal vascular endothelial function in hypertensive patients with type 2 diabetes. Am J Kidney Dis. 2009;53:281–289.
- Futrakul N, Butthep P. Early detection of endothelial injury and dysfunction in conjunction with the correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy. Clin Hemorheol Microcirc. 2006;34:373–381.
- Futrakul P, Yenrudi S, Futrakul N, . Tubular function and tubulointerstitial disease. Am J Kidney Dis. 1999;33:886–891.
- Deekajorndech T. A biomarker for detecting early tubulointerstitial disease and ischemia in glomerulonephropathy. Ren Fail. 2007;29:1013–1017.
- Futrakul N, Kulaputana O, Futrakul P, . Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuria type 2 diabetic nephropathy. Ren Fail. 2011;35:331–335.
- Futrakul N, Futrakul P. Diabetic nephropathy: current concept of therapeutic strategy toward self-sufficiency. J Nephrol Therapeutics, 2011;1:3.